AAAAAA

   
Results: 1-9 |
Results: 9
Pharmacokinetics of celecoxib after oral administration in dogs and humans: Effect of food and site of absorption
Authors: Paulson, SK Vaughn, MB Jessen, SM Lawal, Y Gresk, CJ Yan, B Maziasz, TJ Cook, CS Karim, A
Citation: Sk. Paulson et al., Pharmacokinetics of celecoxib after oral administration in dogs and humans: Effect of food and site of absorption, J PHARM EXP, 297(2), 2001, pp. 638-645
Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia
Authors: de Jonge, E Dekkers, PEP Creasey, AA Hack, CE Paulson, SK Karim, A Kesecioglu, J Levi, M van Deventer, SJH van der Poll, T
Citation: E. De Jonge et al., Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia, J INFEC DIS, 183(12), 2001, pp. 1815-1818
Characterization of metabolites of Celecoxib in rabbits by liquid chromatography/tandem mass spectrometry
Authors: Zhang, JY Wang, Y Dudkowski, C Yang, DC Chang, M Yuan, JH Paulson, SK Breau, AP
Citation: Jy. Zhang et al., Characterization of metabolites of Celecoxib in rabbits by liquid chromatography/tandem mass spectrometry, J MASS SPEC, 35(11), 2000, pp. 1259-1270
Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats
Authors: Paulson, SK Zhang, JY Breau, AP Hribar, JD Liu, NWK Jessen, SM Lawal, YM Cogburn, JN Gresk, CJ Markos, CS Maziasz, TJ Schoenhard, GL Burton, EG
Citation: Sk. Paulson et al., Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats, DRUG META D, 28(5), 2000, pp. 514-521
Metabolism and excretion of [C-14]celecoxib in healthy male volunteers
Authors: Paulson, SK Hribar, JD Liu, NWK Hajdu, E Bible, RH Piergies, A Karim, A
Citation: Sk. Paulson et al., Metabolism and excretion of [C-14]celecoxib in healthy male volunteers, DRUG META D, 28(3), 2000, pp. 308-314
Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey
Authors: Paulson, SK Zhang, JY Jessen, SM Lawal, Y Liu, NWK Dudkowski, CM Wang, YF Chang, M Yang, D Findlay, JWA Berge, MA Markos, CS Breau, AP Hribar, JD Yuan, J
Citation: Sk. Paulson et al., Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey, XENOBIOTICA, 30(7), 2000, pp. 731-744
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
Authors: de Jonge, E Dekkers, PEP Creasey, AA Hack, CE Paulson, SK Karim, A Kesecioglu, J Levi, M van Deventer, SJH van der Poll, T
Citation: E. De Jonge et al., Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia, BLOOD, 95(4), 2000, pp. 1124-1129
Plasma protein binding of celecoxib in mice, rat, rabbit, dog and human
Authors: Paulson, SK Kaprak, TA Gresk, CJ Fast, DM Baratta, MT Burton, EG Breau, AP Karim, A
Citation: Sk. Paulson et al., Plasma protein binding of celecoxib in mice, rat, rabbit, dog and human, BIOPHARM DR, 20(6), 1999, pp. 293-299
Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2inhibitor, celecoxib
Authors: Paulson, SK Engel, L Reitz, B Bolten, S Burton, EG Maziasz, TJ Yan, B Schoenhard, GL
Citation: Sk. Paulson et al., Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2inhibitor, celecoxib, DRUG META D, 27(10), 1999, pp. 1133-1142
Risultati: 1-9 |